The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Syngenta AG

NYSE: SYT
Last

(U.S.) $85.36

Today's change-0.49 -0.57%
Updated February 17 4:04 PM EST. Delayed by at least 15 minutes.
 

Syngenta AG

NYSE: SYT
Last

(U.S.) $85.36

Today's change-0.49 -0.57%
Updated February 17 4:04 PM EST. Delayed by at least 15 minutes.

Syngenta AG crosses below 20-day moving average

Syngenta AG closed lower Friday, dropping (U.S.)$0.49 or 0.57% to (U.S.)$85.36 and crossing below its 20-day moving average. Shares have lost 1.03% over the last five days, but sit 4.23% below their 52-week high. This security has underperformed the S&P 500 by 17.22% during the last year.

Key company metrics

  • Open(U.S.) $85.60
  • Previous close(U.S.) $85.85
  • High(U.S.) $85.69
  • Low(U.S.) $85.25
  • Bid / Ask-- / --
  • YTD % change+7.98%
  • Volume186,664
  • Average volume (10-day)684,661
  • Average volume (1-month)699,624
  • Average volume (3-month)832,679
  • 52-week range(U.S.) $74.52 to (U.S.) $89.13
  • Beta1.03
  • Trailing P/E33.20×
  • P/E 1 year forward22.78×
  • Forward PEG3.04×
  • Indicated annual dividend(U.S.) $2.29
  • Dividend yield2.69%
  • Trailing EPS(U.S.) $2.57
Updated February 17 4:04 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+9.21%

Based on its net profit margin of 9.21%, Syngenta AG is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.16%Sector:Industry:

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q4/2015Q2/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Dec 31, 201512/31/2015Jun 30, 201506/30/2015Dec 31, 201412/31/2014
Revenue7,0945,7777,6346,626
Total other revenue--------
Total revenue7,0945,7777,6346,626
Gross profit3,5252,5983,7712,911
Total cost of revenue3,5693,1793,8633,715
Total operating expense5,7435,5026,0686,246
Selling / general / administrative1,3501,4201,3791,652
Research & development652674688708
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)145222166147
Other operating expenses, total--------
Operating income1,3512751,566380
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax1,2261221,470261
Income after tax1,0661201,224228
Income tax, total160224633
Net income1,0641181,221228
Total adjustments to net income--------
Net income before extra. items1,0641181,221228
Minority interest-2-2-30
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,0641181,221228
Inc. avail. to common incl. extra. items1,0641181,221228
Diluted net income1,0641181,221228
Dilution adjustment------0
Diluted weighted average shares92929292
Diluted EPS excluding extraordinary itemsvalue per share11.581.2813.252.48
Dividends per sharevalue per share0.0010.980.0011.07
Diluted normalized EPSvalue per share13.624.2915.392.78